Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linaclotide for IBS-C Phase 3 Trial in China
CTR20132182Phase 3Completed
- Sponsor
- Ironwood Pharmaceuticals
- Start
- Apr 2014
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of linaclotide in irritable bowel syndrome (IBS), sponsored by Ironwood Pharmaceuticals. Started Apr 2014; status: completed.
02
Drugs
linaclotide
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on CTR20132182.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132182.